NCT03851926View on ClinicalTrials.gov

Hypofractionated Radiotherapy for Prostate Cancer

CompletedOBSERVATIONAL
Enrollment

300

Participants

Timeline

Start Date

October 5, 2016

Primary Completion Date

October 5, 2021

Study Completion Date

October 5, 2021

Conditions
Prostate Cancer
Interventions
RADIATION

Hypofractionated volumetric radiotherapy in 20 fractions

Hypofractionated radiotherapy at 3 Gy per fraction for localized prostate cancer.

Trial Locations (1)

08227

Hospital de Terrassa, Terrassa

All Listed Sponsors
lead

Consorci Sanitari de Terrassa

OTHER

NCT03851926 - Hypofractionated Radiotherapy for Prostate Cancer | Biotech Hunter | Biotech Hunter